Skip to search formSkip to main contentSkip to account menu

drospirenone / Ethinyl Estradiol

Known as: drospirenone, ethinyl estradiol drug combination, Drospirenone/Ethinyl Estradiol, drospirenone and ethinylestradiol 
A combination of two steroid sex hormones, the estrogen ethinyl estradiol and a progestin drospirenone, used for contraceptive purposes. The… 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

AndrostenesEthinyl Estradiol

Narrower (2)

YAZ combinationyasminelle
drospirenone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Characterization of the estrogenic activity of a synthetic adrenal steroid 17-α ethinyl androstenediol and its potential use in hormone replacement therapy.
2010
2010
Drospirenone-ethinylestradiol plus metformin for treatment of polycystic ovarian syndrom
  • Yu Ji
  • 2010
  • Corpus ID: 98873314
Objective To explore the clinical effects of drospirenone-ethinylestradiol(Yasmin) plus metformin on treatment of polycystic… 
2009
2009
[Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial].
OBJECTIVE To evaluate the contraception efficacy, mode of bleeding, side effects and other positive effects of drospirenone… 
2006
2006
Attualità in terapia ormonale sostitutiva a basso dosaggio ed osteoporosi postmenopausale
L’osteoporosi postmenopausale costituisce un serio problema di sanita pubblica. La carenza estrogenica e un fattore chiave nella… 
2005
2005
A pharmaceutical composition containing drospirenone and ethinylestradiol
2001
2001
Cyclodextrin - drospirenone inclusion complexes
2000
2000
A pharmaceutical combination of drospirenone and ethinylestradiol for use as a contraceptive agent
1972
1972
Hormone therapy of breast cancer with special reference to masteril therapy.
From 1968 to 1972, a trial of a new agent, drostanolone propionate (Masteril), was conducted. This agent was tested against… 
1972
1972
Hormonal therapy of breast cancer with special reference to Masteril therapy.
From 1968 to 1972, a trial of a new agent, drostanolone propionate (Masteril), was conducted. This agent was tested against… 
1958
1958
[New oral hormonal drugs in the treatment of cystic glandular hyperplasia: ethinyl-nortestosterone & metropathia haemorrhagica].